Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Lazzeri

Showing results (311-320 of 327) with videos related to

Pageof 33
Sort By:
Cancers|March 11, 2023
Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational TrialRodolfo Hurle, Francesco Soria, Roberto Contieri, et al.
BJU International|July 3, 2025
The role of primary tumour site surgery in metastatic UTUC: a systematic review and meta-analysisLudovica Cella, Stefano Moretto, Roberto Contieri, et al.
BJUI Compass|October 17, 2024
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomyCesare Saitta, Marco Paciotti, Giovanni Lughezzani, et al.
Clinical Genitourinary Cancer|September 24, 2025
Rising Trends of Aggressive Renal Cell Carcinoma Among Younger Adults: Insights From the National Cancer DatabaseGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
European Urology Oncology|February 7, 2026
Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe TrialRoberto Contieri, Marco Paciotti, Alessandro Uleri, et al.
Medicina (Kaunas, Lithuania)|March 28, 2024
Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral CenterCesare Saitta, Giuseppe Garofano, Giovanni Lughezzani, et al.
Clinical Genitourinary Cancer|October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell CarcinomaCesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
BJUI Compass|March 11, 2025
Impact of prostate cancer screening in European ancestry un-affected men with germline DNA repair pathogenic variantsVittorio Fasulo, Giuseppe Chiarelli, Giuseppe Garofano, et al.
Urologic Oncology|November 20, 2025
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinomaGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 5, 2026
[<sup>68</sup>Ga]PSMA-11 PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previous negative biopsy: head to head, parallel, prospective trial (PROSPET-BX)Egesta Lopci, Massimo Lazzeri, Alberto Saita, et al.
Pageof 33

Showing results (311-320 of 327) with videos related to

Sort By:
Pageof 33
Cancers|March 11, 2023
Evaluating the Protective Effect of Intravesical Bacillus Calmette-Guerin against SARS-CoV-2 in Non-Muscle Invasive Bladder Cancer Patients: A Multicenter Observational TrialRodolfo Hurle, Francesco Soria, Roberto Contieri, et al.
BJU International|July 3, 2025
The role of primary tumour site surgery in metastatic UTUC: a systematic review and meta-analysisLudovica Cella, Stefano Moretto, Roberto Contieri, et al.
BJUI Compass|October 17, 2024
Impact of Mayo Adhesive Probability score and BMI on renal functional decline after robotic assisted partial nephrectomyCesare Saitta, Marco Paciotti, Giovanni Lughezzani, et al.
Clinical Genitourinary Cancer|September 24, 2025
Rising Trends of Aggressive Renal Cell Carcinoma Among Younger Adults: Insights From the National Cancer DatabaseGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
European Urology Oncology|February 7, 2026
Second Transurethral Resection of Bladder Tumor Can Be Safely Omitted in Selected Patients with T1 Non-muscle-invasive Bladder Cancer: Results from the Prospective HuNIRe TrialRoberto Contieri, Marco Paciotti, Alessandro Uleri, et al.
Medicina (Kaunas, Lithuania)|March 28, 2024
Preoperative Age and Its Impact on Long-Term Renal Functional Decline after Robotic-Assisted Partial Nephrectomy: Insights from a Tertiary Referral CenterCesare Saitta, Giuseppe Garofano, Giovanni Lughezzani, et al.
Clinical Genitourinary Cancer|October 31, 2024
NODESAFE Nomogram: A Novel Score System to Predict Lymph Node Involvement at the Time of Nephrectomy or Nodal Recurrence in Nonmetastatic Renal Cell CarcinomaCesare Saitta, Giuseppe Garofano, Jonathan A Afari, et al.
BJUI Compass|March 11, 2025
Impact of prostate cancer screening in European ancestry un-affected men with germline DNA repair pathogenic variantsVittorio Fasulo, Giuseppe Chiarelli, Giuseppe Garofano, et al.
Urologic Oncology|November 20, 2025
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinomaGiuseppe Garofano, Cesare Saitta, Giacomo Musso, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 5, 2026
[<sup>68</sup>Ga]PSMA-11 PET/CT vs. mpMRI in patients with a high suspicion of prostate cancer and previous negative biopsy: head to head, parallel, prospective trial (PROSPET-BX)Egesta Lopci, Massimo Lazzeri, Alberto Saita, et al.
Pageof 33